GlassScriptPhysician profile
Sarah A Sankey
NPI 1710521687
$2,607.47
in general payments reported to CMS, 2019-2025
28 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $425 · 2023: $922 · 2024: $604 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Education: $22.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.09 |
| Education | $22.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $501.73 | 2022-2025 | Fasenra, Airsupra, Breztri |
| Actelion Pharmaceuticals US, INC. | $217.80 | 2021-2024 | Uptravi, Opsumit |
| Amgen INC. | $177.59 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.47 | 2021-2024 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Grifols USA, LLC | $156.94 | 2021-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $155.32 | 2021-2025 | |
| United Therapeutics Corporation | $149.70 | 2021-2024 | Orenitram, Remodulin, Tyvaso |
| Genzyme Corporation | $134.43 | 2022-2025 | |
| Insmed, INC. | $125.75 | 2021-2025 | Arikayce |
| Harmony Biosciences LLC | $97.18 | 2022-2024 | Wakix |
| Bayer Healthcare Pharmaceuticals INC. | $73.65 | 2022-2023 | |
| Electromed, INC. | $65.44 | 2022-2025 | Smartvest |
| Glaxosmithkline, LLC. | $59.42 | 2022-2025 | Trelegy Ellipta, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $58.12 | 2021-2025 | Aralast, Glassia |
| Mylan Specialty L.P. | $56.42 | 2022-2023 | Yupelri |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $56.28 | 2022-2024 | Sunosi |
| Verona Pharma, INC. | $56.23 | 2025 | Ohtuvayre |
| Medtronic, INC. | $54.67 | 2025 | Illumisite |
| Mallinckrodt Hospital Products INC. | $34.34 | 2023 | Acthar |
| Avadel Cns Pharmaceuticals, LLC | $32.43 | 2024-2025 | Lumryz |
| Philips North America LLC | $30.81 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $29.14 | 2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $27.00 | 2024-2025 | Dupixent |
| Resmed Corp | $22.23 | 2023 | |
| Edwards Lifesciences Corporation | $20.23 | 2025 | |
| Baxter Healthcare | $16.28 | 2022 | |
| La Jolla Pharmaceutical Company | $15.53 | 2025 | Giapreza |
| Arbor Pharmaceuticals, INC. | $14.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Sankey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.